Danaher splits Life Sciences into Biotechnology and Life Sciences segments, effective Q4 2022

DANAHER CORP /DE/

New four-segment structure: Biotechnology, Life Sciences, Diagnostics, Environmental & Applied Solutions.
Former Life Sciences segment divided due to growth differences; change reflected retrospectively from Q4 2022.
Unaudited recast historical financial data posted at danaher.com under 'Financial Reports'.
Diagnostics and Environmental & Applied Solutions segments unchanged.
Segments marketed under brands including CYTIVA, PALL, BECKMAN COULTER, SCIEX, and others.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.